SIGLEC1 and hepatocellular carcinoma: Patients were divided into two groups, based on the median value of CD204+ or CD169+ Mφ density in the IT regions of HCC (median density, 460 and 112 for CD204+ and CD169+ Mφ, respectively) and GC (median density, 352 and 452 for CD204+ and CD169+ Mφ, respectively).